Postmyocardial Infarction Depression as a Modifiable Secondary Prevention Risk Factor

Area of Science:

• Cardiology
• Psychiatry
• Neuroscience

Background:

• Major depressive disorder (MDD) affects ~25% of myocardial infarction (MI) survivors, significantly higher than the general population.
• Post-MI depression independently predicts mortality, recurrent ischemic events, and hospital readmissions, with risk escalating with symptom severity.
• A bidirectional brain-heart axis links depression to adverse cardiovascular outcomes via mechanisms like autonomic dysregulation and inflammation.

Purpose of the Study:

• To review the impact of post-MI depression on cardiovascular outcomes.
• To explore treatment strategies and the role of cardiac rehabilitation.
• To advocate for integrating depression management into secondary prevention.

Main Methods:

• Literature review of studies on post-MI depression, its cardiovascular impact, and treatment.
• Analysis of evidence regarding the brain-heart axis and therapeutic interventions.
• Examination of the role of cardiac rehabilitation and integrated care models.

Main Results:

• Treatment of post-MI depression improves symptoms and quality of life; SSRIs show potential safety and benefit in cardiac patients.
• Limited randomized evidence exists for definitive reductions in mortality or major adverse cardiovascular events.
• Untreated depression correlates with worse outcomes, highlighting the need for durable remission.
• Cardiac rehabilitation aids recovery and reduces depression, but depression hinders participation.

Conclusions:

• Post-MI depression is a critical, modifiable risk factor requiring systematic integration into cardiovascular care.
• Collaborative care models, stepped-care treatment, and longitudinal screening are vital for enhancing both psychological and cardiovascular health.
• Reframing depression as a secondary prevention target is essential for comprehensive patient management.